Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pace Medical (US) gains FDA approval for infant pacemaker:

This article was originally published in Clinica

Executive Summary

Pace Medical (US) has received FDA approval for its Model 4570 dual-chamber temporary cardiac pacemaker. The device can be used in post-operative open-heart surgery patients of any age, as it is "the only device of its kind in the world that has the ability to sense and pace at high rates in the DDD mode", claims the company. This makes it particularly suitable for use in infants and young children developing temporary heart block following open-heart surgery.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT093512

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel